RecruitingNot applicableNCT05460520
DevRobust Treatment for Mal de Débarquement Syndrome
Studying Mal de débarquement
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Principal Investigator
- Sergei Yakushin, PhDIchan Scool of Medicine at Mount Sinai
- Intervention
- VOR Readaptation(behavioral)
- Enrollment
- 200 target
- Eligibility
- 18-78 years · All sexes
- Timeline
- 2023 – 2027
Study locations (1)
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
Collaborators
New York University · Brooklyn College of the City University of New York · Ohio University · National Institute on Deafness and Other Communication Disorders (NIDCD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05460520 on ClinicalTrials.govOther trials for Mal de débarquement
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07422844Dynamic Network Response to TMS TreatmentGoethe University
- RECRUITINGPHASE2NCT06132178Psilocybin rTMS for Treatment Resistant DepressionUniversity of Texas at Austin
- ENROLLING BY INVITATIONNCT06512324Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness RegistryBiomedical Discoveries and Neuroscientific Foundations LLC